IMAB027
- Generic Name
- IMAB027
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Background
IMAB027 is a chimeric monoclonal antibody against Claudin 6.
- Associated Conditions
- -
- Associated Therapies
- -
Phase 1 Trial of IMAB027 in Patients With Recurrent Advanced Ovarian Cancer (OVAR)
- First Posted Date
- 2014-02-04
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Ganymed Pharmaceuticals GmbH
- Target Recruit Count
- 42
- Registration Number
- NCT02054351
- Locations
- 🇩🇪
UKSH Kiel, Kiel, Schleswig-Holstein, Germany
🇩🇪Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg, Universitätsklinikum Heidelberg, Heidelberg, Baden-Württemberg, Germany
🇧🇪UZ Brussels, Brussels, Belgium
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath